These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 35982904)
1. Tsp2 Facilitates Tumor-associated Fibroblasts Formation and Promotes Tumor Progression in Retroperitoneal Liposarcoma. Xu C; Yan L; Guan X; Wang Z; Wu J; Lv A; Liu D; Liu F; Dong B; Zhao M; Jia L; Tian X; Hao C Int J Biol Sci; 2022; 18(13):5038-5055. PubMed ID: 35982904 [TBL] [Abstract][Full Text] [Related]
2. Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence. Zhang S; Yan L; Cui C; Wang Z; Wu J; Zhao M; Dong B; Guan X; Tian X; Hao C Oncol Rep; 2020 Aug; 44(2):565-576. PubMed ID: 32627015 [TBL] [Abstract][Full Text] [Related]
3. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study. Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724 [TBL] [Abstract][Full Text] [Related]
4. Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence. Cui L; Tian X; Yan L; Guan X; Dong B; Zhao M; Lv A; Liu D; Wu J; Hao C Int J Med Sci; 2022; 19(13):1977-1988. PubMed ID: 36438917 [No Abstract] [Full Text] [Related]
5. Downregulation of RRM2 Attenuates Retroperitoneal Liposarcoma Progression via the Akt/mTOR/4EBP1 Pathway: Clinical, Biological, and Therapeutic Significance. Zhang S; Yan L; Cui C; Wang Z; Wu J; Lv A; Zhao M; Dong B; Zhang W; Guan X; Tian X; Hao C Onco Targets Ther; 2020; 13():6523-6537. PubMed ID: 32753891 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive immune characterization and T-cell receptor repertoire heterogeneity of retroperitoneal liposarcoma. Yan L; Wang Z; Cui C; Guan X; Dong B; Zhao M; Wu J; Tian X; Hao C Cancer Sci; 2019 Oct; 110(10):3038-3048. PubMed ID: 31385405 [TBL] [Abstract][Full Text] [Related]
7. Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells. Harati K; Daigeler A; Hirsch T; Jacobsen F; Behr B; Wallner C; Lehnhardt M; Becerikli M Int J Mol Med; 2016 Jun; 37(6):1535-41. PubMed ID: 27082154 [TBL] [Abstract][Full Text] [Related]
8. Exploring the biological behavior differences between retroperitoneal and non-retroperitoneal liposarcomas. Xi Z; Zhuang A; Li X; Ming TM; Cheng Y; Zhang C; Xie F; Wang Y; Yan G; Zheng J; Lin Z; Zhang G; Li H; Wu T; He Q; Li W Heliyon; 2024 Aug; 10(15):e34878. PubMed ID: 39157358 [TBL] [Abstract][Full Text] [Related]
9. Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Nessim C; Raut CP; Callegaro D; Barretta F; Miceli R; Fairweather M; Blay JY; Strauss D; Rutkowski P; Ahuja N; Gonzalez R; Grignani G; Quagliuolo V; Stoeckle E; Lahat G; De Paoli A; Pillarisetty VG; Canter RJ; Mullen JT; Pennacchioli E; van Houdt W; Swallow CJ; Schrage Y; Cardona K; Fiore M; Gronchi A; Bagaria SP Ann Surg Oncol; 2021 Nov; 28(12):7854-7863. PubMed ID: 33907921 [TBL] [Abstract][Full Text] [Related]
10. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery. Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890 [TBL] [Abstract][Full Text] [Related]
11. TNM classification of malignant tumors: Eighth edition for retroperitoneal liposarcoma. Ways to improve. Nered SN; Volkov AY; Kozlov NA; Stilidi IS; Arhiri PP Asia Pac J Clin Oncol; 2023 Oct; 19(5):e267-e272. PubMed ID: 36385584 [TBL] [Abstract][Full Text] [Related]
12. Multi-omics joint analysis revealed the metabolic profile of retroperitoneal liposarcoma. Xie F; Niu Y; Lian L; Wang Y; Zhuang A; Yan G; Ren Y; Chen X; Xiao M; Li X; Xi Z; Zhang G; Qin D; Yang K; Zheng Z; Zhang Q; Xia X; Li P; Gu L; Wu T; Luo C; Lin SH; Li W Front Med; 2024 Apr; 18(2):375-393. PubMed ID: 38157196 [TBL] [Abstract][Full Text] [Related]
13. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Singer S; Antonescu CR; Riedel E; Brennan MF Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502 [TBL] [Abstract][Full Text] [Related]
14. Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group. Haas RLM; Bonvalot S; Miceli R; Strauss DC; Swallow CJ; Hohenberger P; van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Gladdy R; Jakob J; Szacht M; Fiore M; Chung PW; van Houdt WJ; Raut CP; Gronchi A Cancer; 2019 Apr; 125(8):1290-1300. PubMed ID: 30602058 [TBL] [Abstract][Full Text] [Related]
15. [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases]. Si HP; Wang Z; Fan QH; Zhang YF; Yang DQ; Zhang ZH; Gong QX Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):282-287. PubMed ID: 30955263 [No Abstract] [Full Text] [Related]
16. Comparison of retroperitoneal liposarcoma extending into the inguinal canal and inguinoscrotal liposarcoma. Rhu J; Cho CW; Lee KW; Park H; Park JB; Choi YL; Kim SJ Can J Surg; 2017 Dec; 60(6):399-407. PubMed ID: 28930047 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of prognostic factors for liposarcoma]. Zhang Q; Li JM; Liu JL; Wei YZ Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):943-948. PubMed ID: 31874553 [No Abstract] [Full Text] [Related]
18. [Advances in the etiology of retroperitoneal liposarcoma]. Yuan ZQ; Liu YB Zhonghua Wai Ke Za Zhi; 2024 May; 62(5):472-476. PubMed ID: 38548619 [TBL] [Abstract][Full Text] [Related]
19. Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma. Willis F; Schimmack S; Uhl M; Haefner MF; Mechtersheimer G; Hinz U; Schmidt T; Debus J; Fröhling S; Schneider M Eur J Surg Oncol; 2020 May; 46(5):905-913. PubMed ID: 31892479 [TBL] [Abstract][Full Text] [Related]
20. [Retroperitoneal dedifferentiated liposarcoma with rhabdomyoblastic differentiation: a clinicopathological analysis]. Liu L; Wang LH; Ren YB; Rao XS; Yang SM Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):94-98. PubMed ID: 29429159 [No Abstract] [Full Text] [Related] [Next] [New Search]